ID   KPP-003
AC   CVCL_E6DC
RX   PubMed=37426308;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Unspecified (PubMed=37426308).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
RX   PubMed=37426308; DOI=10.1016/j.jtocrr.2023.100525; PMCID=PMC10329144;
RA   Nakamura R., Fujii H., Yamada T., Matsui Y., Yaoi T., Honda M.,
RA   Tanaka N., Miyagawa-Hayashino A., Yoshimura A., Morimoto K., Iwasaku M.,
RA   Tokuda S., Kim Y.H., Konishi E., Itoh K., Takayama K.;
RT   "Analysis of tumor heterogeneity through AXL activation in primary
RT   resistance to EGFR tyrosine kinase inhibitors.";
RL   JTO Clin. Res. Rep. 4:100525.1-100525.9(2023).
//